Hizuka N, Takano K, Tanaka I, Asakawa K, Miyakawa M, Horikawa R, Shizume K
J Clin Endocrinol Metab. 1987 Jun;64(6):1309-12. doi: 10.1210/jcem-64-6-1309.
Immunoreactive and receptor-reactive insulin-like growth factor I (IGF-I) was demonstrated in human urine. Thirty percent of the IGF-I immunoreactivity in urine was free, and the remainder was a high mol wt form (approximately 43K). Urinary IGF-I was quantitated by RIA after extraction with octadecylsilyl silica cartridges (Sep-Pak C18 cartridge), a method that measures only free IGF-I. The mean urinary immunoreactive IGF-I levels in normal adults (n = 8) and patients with acromegaly (n = 10) or hypopituitarism (n = 9) were 72 +/- 7 (+/- SEM), 225 +/- 34, and 19 +/- 4 pg/mg creatinine, respectively; these mean values were significantly different from one another. The results indicate that IGF-I is present in human urine and that the quantity in urine is altered in patients with GH excess and deficiency.
在人尿液中证实了免疫反应性和受体反应性胰岛素样生长因子I(IGF-I)。尿液中30%的IGF-I免疫反应性是游离的,其余为高分子量形式(约43K)。用十八烷基硅烷硅胶柱(Sep-Pak C18柱)萃取后,通过放射免疫分析法(RIA)对尿液中的IGF-I进行定量,该方法仅测量游离IGF-I。正常成年人(n = 8)、肢端肥大症患者(n = 10)或垂体功能减退患者(n = 9)的尿免疫反应性IGF-I平均水平分别为72±7(±标准误)、225±34和19±4 pg/mg肌酐;这些平均值彼此有显著差异。结果表明,IGF-I存在于人尿液中,且生长激素过多和缺乏患者尿液中的含量会发生改变。